Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0IB3K
|
||||
Former ID |
DNC009165
|
||||
Drug Name |
TILIROSIDE
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527311] | ||
Structure |
Download2D MOL |
||||
Formula |
C30H26O13
|
||||
Canonical SMILES |
C1=CC(=CC=C1C=CC(=O)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4<br />C3=O)O)O)C5=CC=C(C=C5)O)O)O)O)O
|
||||
InChI |
1S/C30H26O13/c31-16-6-1-14(2-7-16)3-10-22(35)40-13-21-24(36)26(38)27(39)30(42-21)43-29-25(37)23-19(34)11-18(33)12-20(23)41-28(29)15-4-8-17(32)9-5-15/h1-12,21,24,26-27,30-34,36,38-39H,13H2/b10-3+/t21-,24-,26+,27-,30+/m1/s1
|
||||
InChIKey |
DVGGLGXQSFURLP-VWMSDXGPSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 3A4 | Target Info | Inhibitor | [527311] | |
PathWhiz Pathway | Caffeine Metabolism | ||||
Retinol Metabolism | |||||
WikiPathways | Metapathway biotransformation | ||||
Aflatoxin B1 metabolism | |||||
Estrogen metabolism | |||||
Benzo(a)pyrene metabolism | |||||
Tamoxifen metabolism | |||||
Tryptophan metabolism | |||||
Oxidation by Cytochrome P450 | |||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
Nuclear Receptors Meta-Pathway | |||||
Farnesoid X Receptor Pathway | |||||
Vitamin D Receptor Pathway | |||||
Felbamate Metabolism | |||||
Lidocaine metabolism | |||||
Nifedipine Activity | |||||
Colchicine Metabolic Pathway | |||||
Irinotecan Pathway | |||||
Drug Induction of Bile Acid Pathway | |||||
Fatty Acid Omega Oxidation | |||||
Codeine and Morphine Metabolism | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.